z-logo
open-access-imgOpen Access
Successful treatment with brentuximab vedotine for a patient with very late relapse of limited stage classic Hodgkin lymphoma
Author(s) -
Jun Nukui,
Hiroyuki Takahashi,
Mayumi Tokunaga,
Taisei Suzuki,
Masaki Suzuki,
Tomoyuki Yokose,
Naoya Nakamura,
Rika Sakai,
Hideaki Nakajima
Publication year - 2021
Publication title -
international cancer conference journal
Language(s) - English
Resource type - Journals
ISSN - 2192-3183
DOI - 10.1007/s13691-021-00510-1
Subject(s) - dacarbazine , brentuximab vedotin , vinblastine , abvd , medicine , bleomycin , stage (stratigraphy) , autologous stem cell transplantation , oncology , lymphoma , radiation therapy , chemoradiotherapy , chemotherapy , hodgkin's lymphoma , vincristine , surgery , hodgkin lymphoma , cyclophosphamide , paleontology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom